Investment Summary

Medivate Partners Invests In SillaJen Biotherapeutics

On March 21, 2016, private equity firm Medivate Partners invested in life science company SillaJen Biotherapeutics

Investment Highlights
  • This is Medivate Partners’ 2nd transaction in the Life Science sector.
  • This is Medivate Partners’ 1st transaction in South Korea.

Investment Summary
Date 2016-03-21
Target SillaJen Biotherapeutics
Sector Life Science
Investor(s) Medivate Partners
Deal Type Growth Capital

Target

SillaJen Biotherapeutics

Busan, South Korea
SillaJen Biotherapeutics is a specializing in the translational and clinical development of complex biologics. The SillaJen translational research, assay, and clinical research teams offer an array of services in a quality systems environment to bring investigational products from bench to bedside. Located on the campus of Pusan National University, the company is comprised of dedicated in-house teams that collaborate closely with a network of local and USA-based world-class scientists and physicians.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Investor(S) 1

Investor

Medivate Partners

Investor Investor Investor

Category Private Equity Firm
Founded 2002
Size Small
Type Sector Focused
DESCRIPTION

Medivate Partners is a private equity and venture capital firm focused on investment in the biotech/healthcare industry. The Firm looks will consider companies throughout Asia and North America and has a particular interest in businesses that can capitalize on cross border opportunities. Medivate Partners was established in 2012 and is headquartered in Seoul.

DEAL STATS #
Overall 2 of 3
Sector (Life Science) 2 of 3
Type (Growth Capital) 2 of 2
Country (South Korea) 1 of 1
Year (2016) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2015-06-26 WCCT Global

Cypress, California, United States

WCCT Global LLC is a multi-site, full service global contract research organization (CRO) of outsourced early drug development and late phase services to the pharmaceutical, biotechnology and medical device industries. WCCT Global is based in Cypress, California.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2018-02-20 Cognate BioServices

Memphis, Tennessee, United States

Cognate BioServices, Inc. is a fully-integrated contract bioservices organization that provides a systematic level of scientific and management expertise. Cognate provides full development and cGMP manufacturing services to companies and institutions engaged in the development and manufacture of cell-based products. Cognate BioServices was founded in 2002 and is based in Memphis, Tennessee.

Buy -
Mergr

Product

Company

Legal